Company

N4 Pharma plc

Headquarters: London, United Kingdom

Employees: 5

CEO: Mr. Nigel James Theobald

LSE: N4P +3.70%

Market Cap

£3.4 Million

GBP as of Jan. 1, 2024

US$4.3 Million

Market Cap History

N4 Pharma plc market capitalization over time

Evolution of N4 Pharma plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of N4 Pharma plc

Detailed Description

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. The company has a research collaboration with Nanomerics Limited to focus on the different formulations of Nuvec delivery system. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

N4 Pharma plc has the following listings and related stock indices.


Stock: LSE: N4P wb_incandescent

Details

Headquarters:

60 Gracechurch Street

6th Floor

London, EC3V 0HR

United Kingdom

Phone: 44 1332 690061